963 related articles for article (PubMed ID: 32096477)
1. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of ANCA-Associated Vasculitis.
Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
[TBL] [Abstract][Full Text] [Related]
8. Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio J; Prieto-González S; Espígol-Frigolé G; Ríos-Garcés R; Gómez-Caverzaschi V; Araújo O; Espinosa G; Jordà-Sánchez R; Alba MA; Quintana L; Blasco M; Guillen E; Viñas O; Ruiz-Ortiz E; Pelegrín L; Sainz de la Maza M; Sánchez-Dalmau B; García-Herrera A; Solé M; Castillo P; Aldecoa I; Cano MD; Sellarés J; Hernández-González F; Agustí C; Lucena CM; López-Rueda A; Sánchez M; Benegas M; Capurro S; Sanmartí R; Grau JM; Vilaseca I; Alobid I; Cid MC; Hernández-Rodríguez J
J Intern Med; 2024 May; 295(5):651-667. PubMed ID: 38462959
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokines in ANCA-associated vasculitis: Correlation with disease-related clinical and laboratory findings.
Krajewska Wojciechowska J; Krajewski W; Kościelska-Kasprzak K; Zatoński T
Med Clin (Barc); 2021 Nov; 157(10):464-472. PubMed ID: 33097207
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
11. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
12. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
[TBL] [Abstract][Full Text] [Related]
14. First-year cumulative myeloperoxidase-ANCA titres are associated with all-cause mortality in patients with microscopic polyangiitis.
Rah W; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2024 Apr; 42(4):887-894. PubMed ID: 38526013
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.
Clain JM; Hummel AM; Stone JH; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; McCune WJ; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Ytterberg SR; Specks U;
Clin Exp Immunol; 2017 Apr; 188(1):174-181. PubMed ID: 28076879
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis.
Wojciechowska J; KręCicki T
Acta Otorhinolaryngol Ital; 2018 Dec; 38(6):517-527. PubMed ID: 30623897
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
[TBL] [Abstract][Full Text] [Related]
20. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]